These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14309376)

  • 21. [CONTRIBUTION TO THE CLINICAL ASPECTS AND THERAPY OF THE CONGENITAL FORM OF THE ANTIBODY DEFICIENCY SYNDROME].
    FALK W; KOCH J; ROSSIPAL E
    Wien Klin Wochenschr; 1964 Jan; 76():35-7. PubMed ID: 14125768
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative study of antibody levels developed by vaccination against polio virus in population after vaccine type alteration.
    Farkas Á; Magyar N; Szomor KN; Takács M
    Acta Microbiol Immunol Hung; 2015 Mar; 62(1):75-85. PubMed ID: 25823455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [SHOULD ATTENUATED POLIOMYELITIS VIRUS VACCINE BE ADMINISTERED TO SUBJECTS PREVIOUSLY VACCINATED BY KILLED VIRUS?].
    GILLET P; THIRY L
    Acta Paediatr Belg; 1964; 18():145-61. PubMed ID: 14166431
    [No Abstract]   [Full Text] [Related]  

  • 24. [ON HETEROLOGOUS ANTIBODY FORMATION AFTER ORAL POLIOMYELITIS VACCINATION].
    SCHMIDT J; NAUMANN G
    Z Immunitats Allergieforsch; 1964 Jul; 127():64-74. PubMed ID: 14259857
    [No Abstract]   [Full Text] [Related]  

  • 25. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].
    Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Gmyl AP; Yakovenko ML; Korotkova EA; Chernjavskaja OP; Baykova OY; Silenova OV; Krasota AY; Krasnoproshina LI; Mustafina AN; Kozlovskaja LI
    Vopr Virusol; 2016; 61(1):9-15. PubMed ID: 27145594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ANTIBODY FORMATION AFTER 3 DOSES OF QUADRUPLE VACCINE INJECTION FOLLOWED BY TRIVALENT ORAL POLIOMYELITIS VACCINE].
    HENIGST W; MUELLER F
    Dtsch Med Wochenschr; 1965 Aug; 90():1502-6. PubMed ID: 14344415
    [No Abstract]   [Full Text] [Related]  

  • 27. [Virological studies and clinical observations following oral poliomyelitis vaccination (Sabin type 1)].
    HAAS R; THOMSSEN R; MAASS G; BADRAN M; VIVELL O; SUETTERLE H
    Dtsch Med Wochenschr; 1963 Mar; 88():557-64. PubMed ID: 13951607
    [No Abstract]   [Full Text] [Related]  

  • 28. [PSYCHIATRIC OBSERVATIONS FOLLOWING POLIOMYELITIS VACCINATION].
    BECHTEL J
    Med Klin; 1964 Feb; 59():263-4. PubMed ID: 14135758
    [No Abstract]   [Full Text] [Related]  

  • 29. [VIROLOGICAL AND SEROLOGICAL STUDIES RELATED TO THE ORAL POLIOMYELITIS VACCINATION (SABIN TYPE I) IN SCHLESWIG-HOLSTEIN 1962].
    WITT G
    Zentralbl Bakteriol Orig; 1963 Jul; 189():345-7. PubMed ID: 14049327
    [No Abstract]   [Full Text] [Related]  

  • 30. [COMPLICATIONS FOLLOWING ORAL POLIOMYELITIS VACCINATION].
    PETERS G
    Nervenarzt; 1964 Mar; 35():132-3. PubMed ID: 14183549
    [No Abstract]   [Full Text] [Related]  

  • 31. [USE OF HOMOTYPIC ORAL ANTIPOLIOMYELITS VACCINATION IN AN EPIDEMIC CAUSED BY TYPE I POLIOMYELITIS VIRUS IN FRANCE].
    DEBRE R; COULON G; LEDOURNEUF G; GAUTIER M; CELERS J; DROUHET V; BOUE A
    Bull World Health Organ; 1964; 30(5):663-74. PubMed ID: 14196814
    [No Abstract]   [Full Text] [Related]  

  • 32. [ON THE OCCURRENCE OF A POLIOMYELITIS OUTBREAK IN THE COMMUNE OF CARRARA AFTER THE VACCINATION CAMPAIGN OF 1958-1960 WITH SALK VACCINE].
    BARGHINI G; GALLO G
    Riv Ital Ig; 1964; 24():590-6. PubMed ID: 14337305
    [No Abstract]   [Full Text] [Related]  

  • 33. [IMMUNITY TO POLIOMYELITIS 4 YEARS FOLLOWING ORAL VACCINATION].
    JUST M; RITZEL G
    Schweiz Med Wochenschr; 1965 Jan; 95():1-4. PubMed ID: 14306411
    [No Abstract]   [Full Text] [Related]  

  • 34. POLIOMYELITIS IN ISRAEL, 1949 TO 1963, AND THE RECENT USE OF ATTENUATED POLIOMYELITIS VACCINES IN ITS CONTROL.
    GOLDBLUM N; YOFE Y; EYLAN E
    Isr J Med Sci; 1965 Mar; 1():235-42. PubMed ID: 14279071
    [No Abstract]   [Full Text] [Related]  

  • 35. [SEROLOGICAL SURVEY OF CHILDREN FOR ANTIBODIES TO POLIOMYELITIS VIRUSES IN MOSCOW IN 1962].
    VOROSHILOVA MK; TARANOVA GP; EMELIANENKOVA VP; SHCHEGLOVA AP; KAPLAN SB
    Vopr Virusol; 1963; 29():404-9. PubMed ID: 14071275
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antibody deficiency syndrome; observations on a case of agammaglobulinemia].
    Hertenstein C; Konrads J; Mayer-Birkhof KR; Wetter O
    Med Klin; 1966 Dec; 61(49):1965-9. PubMed ID: 4166166
    [No Abstract]   [Full Text] [Related]  

  • 37. [VACCINATION AGAINST POLIOMYELITIS IN BELGIUM].
    BORDET P
    Brux Med; 1964 Sep; 44():907-11. PubMed ID: 14197808
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antipoliomyelitis vaccination campaign and comparative evaluation of the vaccines].
    VALENTIN MATILLA D
    An R Acad Nac Med (Madr); 1963; 80():161-84. PubMed ID: 13995862
    [No Abstract]   [Full Text] [Related]  

  • 39. THE POLIOMYELITIS IMMUNIZATION PROGRAMME IN SINGAPORE.
    LEE LH; LIM KA; KANAGARATNAM K
    Singapore Med J; 1965 Jun; 5():89-95. PubMed ID: 14341533
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunoglobulin deficiency syndrome and agranulocytosis in thyoma].
    Thiele HG; Frenzel H
    Schweiz Med Wochenschr; 1967 Dec; 97(48):1606-11. PubMed ID: 4875897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.